M. Ragni

R. Spiro, C. M. Culley, D. Triulzi, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Bleeding Disorders: Diagnosis and Treatment of Hemorrhagic Complications in the Intensive Care Unit

M. Ragni, C. Seaman, Craig D. Seaman, 2017 .

Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model.

Lina L. Lu, M. Ragni, Ching-Chuan Hsieh, 2009, Experimental hematology.

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.

S. Belle, M. Ragni, M. Ragni, 2001, The Journal of infectious diseases.

Gene therapy in hemophilia A: a cost-effectiveness analysis.

Kenneth J. Smith, M. Ragni, N. Machin, 2018, Blood advances.

Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.

Kenneth J. Smith, M. Ragni, Anna K. Donovan, 2013, Thrombosis research.

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

A. Akinc, D. Bevan, K. Pasi, 2017, The New England journal of medicine.

Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database

M. Ragni, L. Malec, J. Li, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Von Willebrand Disease Screening in Adolescents with Menorrhagia — A Decision Analysis and Review

M. Ragni, Robert Francis S idonio, 2022 .

Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.

M. Ragni, 2019, Hematology. American Society of Hematology. Education Program.

von Willebrand Disease: Differential Diagnosis and Diagnostic Approach to Specific Subtypes

M. Ragni, 2016 .

Bleeding and liver transplantation outcomes in haemophilia

M. Ragni, K. Mehta, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

K. Pasi, T. Lissitchkov, M. Ragni, 2021, Journal of thrombosis and haemostasis : JTH.

Infection with human immunodeficiency virus and vulnerability to psychiatric distress. A study of men with hemophilia.

M. Dew, M. Ragni, P. Nimorwicz, 1990, Archives of general psychiatry.

Hormones and Thrombosis: Risk Across the Reproductive Years and Beyond.

M. Ragni, N. Machin, Nicoletta Machin, 2020, Translational research : the journal of laboratory and clinical medicine.

Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice.

S. Qian, Lina L. Lu, M. Ragni, 2015, Experimental hematology.

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

J. Oldenburg, J. Mahlangu, R. Klamroth, 2016, Thrombosis and Haemostasis.

Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis

D. Brambilla, M. Ragni, J. Journeycake, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease

T. Nichols, M. Ragni, E. Merricks, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

The design of a Bayesian platform trial to prevent and eradicate inhibitors in patients with hemophilia.

M. Bertolet, M. Ragni, M. Brooks, 2020, Blood advances.

Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in pre-capillary pulmonary arterioles.

Simon C Watkins, M. Gladwin, M. Neal, 2020, JCI insight.

Importance of age in prognostic staging system for AIDS.

L. Kingsley, M. Ragni, 1989, The New England journal of medicine.

Organ transplantation in HIV-positive patients with hemophilia.

J. Lewis, M. Ragni, F. Bontempo, 1990, The New England journal of medicine.

Periprocedural management of von Willebrand disease: An institutional experience

M. Ragni, C. Seaman, Craig D. Seaman, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

M. Ragni, 2017, Blood advances.

Feasibility of the Von Willebrand disease PREVENT trial.

A. Neff, C. Kessler, B. Konkle, 2017, Thrombosis research.

THROMBOSIS AND HEMOSTASIS No increase in bleeding identi fi ed in type 1 VWD subjects with D 1472 H sequence variation

R. Hoffmann, C. Leissinger, R. Montgomery, 2013 .

Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A

T. Nichols, M. Ragni, E. Merricks, 2012, Thrombosis and Haemostasis.

177 – Hemorrhagic Disorders: Coagulation Factor Deficiencies

M. Ragni, 2012 .

Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia

T. Nichols, M. Ragni, E. Merricks, 2011, Thrombosis and Haemostasis.

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies

D. Bellinger, T. Nichols, M. Ragni, 2011, Thrombosis.

Bleeding manifestations in males with von Willebrand disease

M. Ragni, O. Ziv, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor development in two cousins receiving full‐length factor VIII (FVIII) and FVIII‐Fc fusion protein

M. Ragni, L. Malec, M. Alabek, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Extended half‐life factor VIII for immune tolerance induction in haemophilia

M. Ragni, L. Malec, J. Journeycake, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

A. Bitonti, J. Dumont, L. Valentino, 2012, Blood.

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

P. Noris, A. Srivastava, V. Blanchette, 2019, HemaSphere.

Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study

E. Kraut, T. Buckner, Michael Wang, 2022, Journal of thrombosis and haemostasis : JTH.

Lymphoma presenting as a traumatic hematoma in an HTLV-III antibody-positive hemophiliac.

J. Lewis, M. Ragni, F. Bontempo, 1985, The New England journal of medicine.

Coagulopathy in Cirrhosis

M. Ragni, C. Seaman, Craig D. Seaman, 2017 .

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.

M. Ragni, 2013, Hematology. American Society of Hematology. Education Program.

Safety of the new generation recombinant factor concentrates

M. Ragni, K. Schlesinger, 2002, Expert opinion on drug safety.

Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery

C. Leissinger, T. Buckner, C. Kempton, 2016, Thrombosis and Haemostasis.

Acquired anti‐FVIII inhibitors in children

M. Ragni, R. Moraca, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Von Willebrand disease in the emergency department

D. Yealy, K. Livesey, M. Ragni, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors

M. Ragni, M. Torres, J. Sanders, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

A multicenter study of viral hepatitis in a United States hemophilic population.

R. Parmley, C. Contant, J. Gill, 1993, Blood.

Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study.

A. Folsom, M. Ragni, C. Seaman, 2016, Thrombosis research.

Inflammatory Bowel Disease and Thrombosis: A National Inpatient Sample Study

M. Ragni, J. Yabes, D. Comer, 2020, TH Open.

Natural history study of factor IX deficiency with focus on treatment and complications (B‐Natural)

J. Astermark, J. Oldenburg, C. Kempton, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

M. Ragni, C. Seaman, L. D. De Castro, 2020, Pilot and Feasibility Studies.

Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease

M. Gladwin, M. Meyer, G. Kato, 2013, Haematologica.

Pulmonary embolism in sickle cell disease: a case–control study

M. Gladwin, M. Ragni, E. Novelli, 2012, Journal of thrombosis and haemostasis : JTH.

Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

L. Kingsley, S. Belle, D. Brettler, 1993, Blood.

Hemophilia gene transfer: comparison with conventional protein replacement therapy.

M. Ragni, 2004, Seminars in thrombosis and hemostasis.

An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B

M. Ragni, N. Machin, 2018, Journal of blood medicine.

Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions.

J. Lewis, M. Ragni, O. Reinmuth, 1986, Stroke.

Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study.

M. Ragni, J. Yabes, D. Comer, 2018, Thrombosis research.

The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand Disease

M. Ragni, C. Seaman, Craig D. Seaman, 2020, Thrombosis and Haemostasis.

Platelet VIII pack evades immune detection.

M. Ragni, 2016, Blood.

Liver transplantation: Intraoperative changes in coagulation factors in 100 first transplants

T. Starzl, M. Ragni, J. Kiss, 1989, Hepatology.

Blood use in liver transplantation

T. Starzl, J. Lewis, M. Ragni, 1987, Transfusion.

THE RELATION OF PREOPERATIVE COAGULATION FINDINGS TO DIAGNOSIS, BLOOD USAGE, AND SURVIVAL IN ADULT LIVER TRANSPLANTATION

D. V. van Thiel, T. Starzl, J. Lewis, 1985, Transplantation.

Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate

M. Ragni, J. Blatt, M. Ragni, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study

C. Kempton, P. Monahan, M. Ragni, 2015, Journal of thrombosis and haemostasis : JTH.

Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis.

Kenneth J. Smith, M. Ragni, Brenna S Monsef, 2008, Thrombosis and haemostasis.

Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans.

A. Justice, S. Fultz, M. Ragni, 2004, The American journal of medicine.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

D. Stablein, L. Ferrell, K. Olthoff, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

HIV heterosexual transmission in hemophilia couples: lack of relation to T4 number, clinical diagnosis, or duration of HIV exposure.

L. Kingsley, C. Rinaldo, M. Ragni, 1989, Journal of acquired immune deficiency syndromes.

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

M. Ragni, N. Machin, 2020, Blood advances.

Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men

B. J. Miller, M. Ragni, R. Ptachcinski, 1992, American journal of hematology.

INCREASED FREQUENCY OF HAEMARTHROSES IN HAEMOPHILIC PATIENT TREATED WITH ZIDOVUDINE

M. Ragni, M. Ho, J. Lewis, 1988, The Lancet.

Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice

Simon C Watkins, D. Stolz, M. Ragni, 2022, Blood advances.

New‐generation recombinant factor concentrates: bridge to gene therapy

M. Ragni, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates

M. Gladwin, M. Meyer, G. Kato, 2012, American journal of hematology.

Anticardiolipin Antibody Associated Arterial Thrombosis following Fibula Fracture

J. Fenwick, G. Gruen, M. Ragni, 2003, Foot & ankle international.

Aging in Haemophilia: Getting to the heart of the matter

M. Ragni, 2011, Thrombosis and Haemostasis.

Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome

M. Ragni, L. Malec, M. Michaels, 2017, Journal of pediatric gastroenterology and nutrition.

Liver transplantation in a hemophiliac.

T. Starzl, J. Lewis, M. Ragni, 1985, The New England journal of medicine.

Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease.

J. Lewis, M. Ragni, U. Hasiba, 1982, Alcoholism, clinical and experimental research.

Viral pathogens

J. Jordan, M. Ragni, K. Sherman, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report

L. Shaw, M. Korecka, J. Fung, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct‐acting antiviral agents: A national inpatient sample study

M. Ragni, J. Yabes, Xi Yang, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion".

M. Ragni, F. Bontempo, O. Ndimbie, 1993, Blood.

Bleeding disorders in premenopausal women: (another) public health crisis for hematology?

V. Picozzi, A. James, M. Ragni, 2006, Hematology. American Society of Hematology. Education Program.

A Multicenter Study of Viral Hepatitis in a United States Hemophilic Population

R. Parmley, C. Contant, J. Gill, 1993 .

Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open‐label, 3 × 3 crossover trial

M. Ragni, C. Seaman, J. Yabes, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial

M. Ragni, 2011, Expert review of hematology.

Coronary atherosclerosis and cardiovascular mortality in hemophilia

Carolyn J Foley, M. Ragni, L. Nichols, 2010, Journal of thrombosis and haemostasis : JTH.

Efficacy of a sucrose‐formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A

M. Ragni, H. Brackmann, I. Scharrer, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group.

L. Kingsley, S. Swindells, S. Belle, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

D. Bellissimo, C. Leissinger, R. Montgomery, 2012, Blood.

Screening for von Willebrand disease in children: a case–control study

C. Kempton, P. Kouides, M. Ragni, 2011, Journal of thrombosis and haemostasis : JTH.

Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.

M. Ragni, M. Ragni, F. Bontempo, 1999, The Journal of infectious diseases.

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV‐HBV Coinfected Transplant Recipients

N. Terrault, P. Stock, C. Coffin, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia.

G. Roodman, L. Moscinski, M. Ragni, 2010, Blood.

Emerging clinical concerns in the ageing haemophilia patient

C. Kessler, D. Quon, B. Konkle, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts < or = 200/mm3.

M. Ragni, M. Ragni, L. Crossett, 1995, The Journal of arthroplasty.

Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates

M. Ozelo, C. Négrier, A. Shapiro, 2015, British journal of haematology.

Clinical evaluation of recombinant factor IX.

P. Garzone, M. Ragni, G. White, 1998, Seminars in hematology.

WFH Guidelines for the Management of Hemophilia, 3rd edition

E. Santagostino, M. Carcao, B. Feldman, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Combined clotting factor deficiencies: experience at a single hemophilia treatment center

S. O’Brien, A. Ritchey, M. Ragni, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins

M. Ragni, 2015, Drugs.

Hemophilia A (Factor VIII Deficiency).

M. Ragni, C. Seaman, F. Xavier, 2021, Hematology/oncology clinics of North America.

Mimicking Factor VIII to Manage the Factor VIII-Deficient State.

M. Ragni, 2018, The New England journal of medicine.

Pilot randomized, non‐inferiority, cross‐over trial of once‐weekly vs. three times‐weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A

A. Neff, C. Kessler, M. Ragni, 2017, Haemophilia.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B.

J. Oldenburg, D. Perry, M. Ozelo, 2016, Thrombosis and haemostasis.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein ( rFIXFc ) in subjects with haemophilia

J. Oldenburg, D. Perry, M. Ozelo, 2017 .

Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.

J. Dumont, D. Perry, L. Valentino, 2013, The New England journal of medicine.

Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study

C. Hermans, D. Perry, M. Ozelo, 2015, British journal of haematology.

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery

K. Pasi, M. Ragni, G. White, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

J. Dumont, I. Nestorov, D. Quon, 2014, Journal of thrombosis and haemostasis : JTH.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

J. Dumont, I. Nestorov, D. Perry, 2014, Blood.

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.

D. Quon, J. Staber, B. Konkle, 2020, The New England journal of medicine.

Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B.

M. Recht, A. Rauch, K. Fischer, 2021, Blood advances.

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

J. Oldenburg, M. Ozelo, H. Chambost, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

construct administered by peripheral intravenous infusion Phase I trial of FVIII gene transfer for severe hemophilia A using a retroviral

E. Tom, H. Roehl, M. Ragni, 2013 .

retroviral construct administered by peripheral intravenous infusion Phase 1 trial of FVIII gene transfer for severe hemophilia A using a

H. Roehl, M. Ragni, G. White, 2013 .

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.

H. Roehl, M. Ragni, G. White, 2003, Blood.

General surgery in adult hemophiliacs.

D. Steed, M. Webster, M. Makaroun, 1986, Surgery.

Septic arthritis in hemophilic patients and infection with human immunodeficiency virus (HIV)

M. Ragni, E. Hanley, 1989, Annals of internal medicine.

Neutrophil Extracellular Traps Promote Joint Injury in Hemophilia

M. Ragni, P. Sundd, E. Tutuncuoglu, 2020, Blood.

Von Willebrand disease and gastrointestinal bleeding: A national inpatient sample study.

M. Ragni, J. Yabes, D. Comer, 2019, Thrombosis research.

Patterns of gastrointestinal hemorrhage in hemophilia.

D. V. van Thiel, J. Lewis, M. Ragni, 1985, Gastroenterology.

Genetics of bleeding disorders in women.

M. Ragni, E. Novelli, 2008, Seminars in thrombosis and hemostasis.

Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A.

M. Ragni, L. Malec, C. Seaman, 2020, Thrombosis research.

Prevalence and Risk Factors Associated With Hypertension in Hemophilia: Cross-Sectional Analysis of a National Discharge Register

M. Ragni, C. Seaman, J. Yabes, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors

M. Ragni, C. Seaman, Patrick T. Ebbert, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.

M. Hannan, A. Shapiro, M. Ragni, 1996, Thrombosis and Haemostasis.

Antithrombin III during liver transplantation.

T. Starzl, J. Lewis, M. Ragni, 1989, Transplantation proceedings.

Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation

M. Ragni, P. Lamont, 2005, Journal of thrombosis and haemostasis : JTH.

A cross-sectional analysis of cardiovascular disease in the hemophilia population.

C. Leissinger, C. Kempton, C. Kessler, 2018, Blood advances.

More on: are randomized clinical trials the only truth? Not always

P. Mannucci, C. Kessler, P. Monahan, 2006, Journal of thrombosis and haemostasis : JTH.

hemophilia A Phase 3 study of recombinant factor VIII Fc fusion protein in severe

J. Dumont, I. Nestorov, D. Perry, 2014 .

What is the role of prophylaxis in the improvement of health-related quality of life of patients with hemophilia?

M. Ragni, D. Buchbinder, 2013, Hematology. American Society of Hematology. Education Program.

The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.

L. Kingsley, M. Ragni, S. Zhou, 1992, Journal of acquired immune deficiency syndromes.

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies

M. Ozelo, S. Lethagen, K. Pasi, 2022, Research and practice in thrombosis and haemostasis.

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA

C. Négrier, K. Pasi, T. Lissitchkov, 2020 .

Emicizumab use in major orthopedic surgery.

M. Ragni, C. Seaman, 2019, Blood advances.

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

A. Iorio, M. Morfini, M. Cnossen, 2018, Journal of thrombosis and haemostasis : JTH.

Measuring success in hemophilia gene therapy using a factor level & outcomes yardstick

M. Ragni, N. Machin, 2018, Expert review of hematology.

Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies

A. Weill, M. Skinner, S. Pipe, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment of Hemophilia: Interim Weekly and Monthly Dosing Results in Patients with Hemophilia A or B

A. Akinc, D. Bevan, K. Pasi, 2015 .

Targeting Antithrombin to Treat Hemophilia.

M. Ragni, 2015, The New England journal of medicine.

Safe passage: a plea for safety in hemophilia gene therapy.

M. Ragni, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Survey of Current Prophylaxis Practices and Bleeding Characteristics of Children with Severe Hemophilia A In U.S. Hemophilia Treatment Centers.

A. Neff, C. Kessler, M. Ragni, 2010 .

Hemophilia Liver Transplantation Observational Study

D. Stablein, P. Stock, J. Fung, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

population A multicenter study of viral hepatitis in a United States hemophilic

R. Parmley, C. Contant, J. Gill, 2011 .

Highly active antiretroviral therapy improves ESLD‐free survival in HIV‐HCV co‐infection

M. Ragni, M. Nalesnik, R. Schillo, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical manifestations and management of labor and delivery in women with factor IX deficiency *

M. Ragni, M. Yang, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States

M. Recht, C. Witmer, P. Kouides, 2020, American journal of hematology.

Liver transplantation in hemophilia A.

T. Starzl, J. Scott, J. Lewis, 1987, Blood.

Prenatal diagnosis by droplet digital PCR.

M. Ragni, 2017, Blood.

Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis.

M. Ragni, C. Seaman, 2017, Blood advances.

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

C. Négrier, S. Pipe, M. Ragni, 2019, Blood.

Patterns of Gastrointestinal in Hemophilia Hemorrhage

J. Lewis, M. Ragni, D. Thiel, 1985 .

FVIII, CD4, and liaisons dangereuses.

M. Ragni, 2011, Blood.

Clinical Outcomes of Weekly Prophylaxis with rFVIIIFc: Longitudinal Analysis of the A-LONG and ASPIRE Study Population

D. Quon, S. Lethagen, A. Shapiro, 2017 .

Perioperative Management in Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia

C. Négrier, K. Pasi, T. Lissitchkov, 2017 .

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

L. Valentino, X. Anguela, M. Carr, 2018, Blood.

The effect of emicizumab regimen on haemophilia outcomes.

M. Ragni, 2019, The Lancet. Haematology.

Thrombosis Complicating Non-Factor Therapy for Hemophilia

M. Ragni, 2021, Medical Research Archives.

Challenges of rare disease research: limited patients and competing priorities

C. Francis, N. Key, P. Kouides, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Von Willebrand factor for menorrhagia: a survey and literature review

A. Neff, C. Kessler, B. Konkle, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Subject-Reported Changes in Physical Activity During The B-LONG Study of Recombinant Factor IX FC Fusion Protein (RFIXFC) For Severe Haemophilia B

M. Ozelo, M. Ragni, J. Windyga, 2015 .

A cross-sectional analysis of cardiovascular disease in the hemophilia population.

C. Leissinger, C. Kempton, A. Neff, 2014, Blood advances.

A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B

Creagh, A. Akinc, D. Bevan, 2016 .

Immune hemolysis by isohemagglutinins in factor IX concentrates

M. Ragni, J. Lewis, M. Ragni, 1987, Transfusion.

Parvovirus B19 infection in patients with hemophilia

M. Ragni, J. Jordan, W. Koch, 1996, Transfusion.

1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B.

L. Kingsley, J. Lewis, M. Ragni, 1987, Blood.

Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds.

D. Sinha, P. Walsh, J. Lewis, 1985, Blood.

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.

C. Kempton, P. Mannucci, E. Romond, 2013, Blood.

Immune Tolerance Induction Using Rfviiifc (Eloctate)

M. Ragni, L. Malec, J. Journeycake, 2015 .

Optical or optimal conclusion: pharmacokinetic-guided dosing in haemophilia.

M. Ragni, 2021, The Lancet. Haematology.

B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subjects With Severe Hemophilia B

J. Oldenburg, K. Pasi, K. Fischer, 2018, Blood.

Model of the impact of HIV infection on the size of future hemophilia and carrier birth cohorts.

J. Weissfeld, M. Ragni, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapy.

M. Ragni, 2017, Hematology. American Society of Hematology. Education Program.

Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection.

M. Ragni, F. Ruben, J. Spero, 1987, The Journal of laboratory and clinical medicine.

Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

B. Konkle, P. Kouides, A. James, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease

B. Konkle, C. Witmer, A. Shapiro, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevalence and Risk Factors Associated With Hypertension in von Willebrand Disease

M. Ragni, C. Seaman, J. Yabes, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia.

Kenneth J. Smith, M. Ragni, R. Sidonio, 2009, The Journal of pediatrics.

The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

S. O’Brien, C. Minard, P. Kouides, 2020, Blood advances.

Validation Study of the Composite Score to Identify Von Willebrand Disease in Children

C. Moore, B. Kerlin, C. Witmer, 2013, Journal of pediatric hematology/oncology.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

R. Hoffmann, C. Leissinger, P. Morateck, 2010, Blood.

The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD).

D. Bellissimo, C. Leissinger, R. Montgomery, 2007 .

Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing.

D. Bellissimo, C. Leissinger, R. Montgomery, 2007 .

Bleeding Score as a Preoperative Predictor of Postoperative Bleeding in Type 1 Von Willebrand Disease.

M. Ragni, L. Goldberg, 2006 .

Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: A National Inpatient Sample Study

M. Ragni, J. Yabes, D. Comer, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register

M. Ragni, C. Seaman, J. Yabes, 2015, Journal of Thrombosis and Haemostasis.

Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men.

W. Darrow, N. Hessol, K. Lui, 1989, JAMA.

AIDS and treatment of hemophilia patients

M. Ragni, 1988 .

Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs.

M. Ragni, J. Spero, J. Lewis, 1988, AIDS research and human retroviruses.

M. Ragni, J. Spero, J. Lewis, 1987, The Lancet.

Liver Transplantation in Hemophilia A

T. Starzl, J. Scott, M. Ragni, 1987 .

Quality of periprocedural care in patients with von Willebrand disease

M. Bertolet, M. Ragni, C. Seaman, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers.

M. Ragni, K. Pratt, Debargh Dutta, 2016, Blood advances.

Factor VIII Intron 22 Inversion Screening of Newborn Males for Hemophilia A: A Cost-Effectiveness Study

Kenneth J. Smith, M. Ragni, R. Sidonio, 2010 .

ndomized Study of Didanosine Monotherapy and Combination Therapy With Zidovudine in Hemophilic and Nonhemophilic Subjects With Asymptomatic Human Immunodeficiency Virus-l Infection

T. Merigan, U. Dafni, V. DeGruttola, 2002 .

Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.

V. DeGruttola, C. Kessler, M. Ragni, 1995, Blood.

Pneumocystis carinii infection presenting as necrotizing thyroiditis and hypothyroidism.

S. Goold, F. DeRubertis, M. Ragni, 1991, American journal of clinical pathology.

ACQUIRED-IMMUNODEFICIENCY-LIKE SYNDROME IN TWO HAEMOPHILIACS

M. Ragni, F. Bontempo, J. Spero, 1983, The Lancet.

Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.

J. Fung, M. Ragni, J. Fung, 1999, Blood.

Transplantation in HIV+ patients.

T E Starzl, J. Ward, T. Starzl, 1990, Transplantation.

Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients

J. Fung, R. Shapiro, B. Eghtesad, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver transplantation in patients with HIV infection

J. Fung, B. Eghtesad, M. Ragni, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Survival of human immunodeficiency virus-infected liver transplant recipients.

N. Heaton, S. Belle, P. Stock, 2003, The Journal of infectious diseases.

Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease

E. Schiff, J. Fung, A. Tzakis, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Updated Results from a Phase 1 and Phase 1/2 Extension Study in Patients without Inhibitors

A. Akinc, D. Bevan, K. Pasi, 2016 .

the VWF activity assay by ristocetin cofactor Common VWF exon 28 polymorphisms in African Americans affecting

R. Hoffmann, C. Leissinger, P. Morateck, 2012 .

An immunologic study of spouses and siblings of asymptomatic hemophiliacs.

B. Rabin, M. Ragni, J. Lewis, 1983, Blood.

The use of thromboelastography for the peripartum management of a patient with platelet storage pool disorder.

J. Waters, M. Ragni, M. Vallejo, 2011, International journal of obstetric anesthesia.

Intraoperative coagulation changes in liver transplantation

T. Starzl, M. Ragni, Yoogoo Kang, 1986 .

Prekallikrein (Fletcher factor) deficiency in clinical disease states.

J. Lewis, M. Ragni, U. Hasiba, 1980, Thrombosis research.

Ascites‐induced LeVeen Shunt Coagulopathy

J. Lewis, M. Ragni, J. Spero, 1983, Annals of surgery.

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

J. Fung, V. Scantlebury, R. Shapiro, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Plasma Fibronectin Levels in Clinical Disease States and After Cryoprecipitate Infusion

M. Ragni, F. Bontempo, J. Spero, 1984, Thrombosis and Haemostasis.

Progression of HIV in haemophilia

C. Kessler, M. Ragni, U. Martinowitz, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Heterosexual HIV-1 transmission and viral load in hemophilic patients.

L. Kingsley, M. Ragni, M. Ragni, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Hemophilia as a blueprint for gene therapy

M. Ragni, 2021, Science.

Correlates of psychiatric distress among wives of hemophilic men with and without HIV infection.

M. Dew, M. Ragni, P. Nimorwicz, 1991, The American journal of psychiatry.

TRANSPLANT A TION IN HIV+ P A TIENTS 1 ,2

J. Ward, T. Starzl, A. Tzakis, 1990 .

ACQUIRED IMMUNODEFICIENCY SYNDROME IN THE CHILD OF A HAEMOPHILIAC

B. Rabin, M. Ragni, F. Bontempo, 1985, The Lancet.

HETEROSEXUAL PARTNERS OF HAEMOPHILIACS MUST REFRAIN FROM BLOOD DONATION

C. Rinaldo, M. Ragni, L. Kingsley, 1986, The Lancet.

HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs.

L. Kingsley, M. Ragni, C. Rinaldo, 1988, Public health reports.

Recurrent infections and lymphadenopathy in the child of a hemophiliac: a survey of children of hemophiliacs positive for human immunodeficiency virus antibody.

J. Lewis, M. Ragni, F. Bontempo, 1986, Annals of Internal Medicine.

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

D. Stablein, P. Stock, J. Fung, 2010, Gastroenterology.

Pretransplant survival is shorter in HIV‐positive than HIV‐negative subjects with end‐stage liver disease

J. Fung, B. Eghtesad, M. Ragni, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Cumulative risk for AIDS and other HIV outcomes in a cohort of hemophiliacs in western Pennsylvania.

L. Kingsley, M. Ragni, 1990, Journal of acquired immune deficiency syndromes.

Human immunodeficiency virus transmission and hemophilia.

M. Ragni, P. Nimorwicz, 1989, Archives of internal medicine.

Spontaneous "remission' of agnogenic myeloid metaplasia and termination in acute myeloid leukemia.

M. Ragni, D. Shreiner, 1981, Archives of internal medicine.

Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity

F. Guyette, J. Sperry, M. Neal, 2020, Transfusion.

Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver.

M. Ragni, P. Fontes, C. Madeira, 2009, Blood.

Primary Malignant Melanoma of the Vagina and Vulva

M. Ragni, H. Tobón, 1974, Obstetrics and gynecology.

Pulmonary embolism and spiral computerized tomographic scans

M. Ragni, 2009 .

Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.

C. Moore, Jie Li, M. Ragni, 2014, Thrombosis research.

Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs.

M. Ragni, J. Kiss, F. Bontempo, 1990, Blood.

Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations

S. O’Brien, J. Di Paola, C. Minard, 2021, Blood advances.

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding

C. Langmead, E. Neufeld, R. Lewis, 2023, Expert review of hematology.

Unsuspected Lyme disease presenting in refractory haemophilic haemarthrosis

L. Maurer, M. Ragni, J. Cooper, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors

M. Ragni, L. George, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease

M. Ragni, Tirthadipa Pradhan-Sundd, Shweta Gudapati, 2021, Cellular and molecular gastroenterology and hepatology.

Reduction of Factor VIII Inhibitor Formation with F.VIII-Pulsed Tolerogenic Dendritic Cells in the Murine Hemophilia A Model.

Lina L. Lu, M. Ragni, Wenhui Wu, 2005 .

Valoctocogene roxaparvovec gene transfer in participants with HIV

S. Fong, M. Ragni, E. Majerus, 2023, Blood advances.

Pulmonary embolism incidence is increasing with use of spiral computed tomography.

W. Kapoor, Q. Dang, M. Ragni, 2008, The American journal of medicine.

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective.

Kenneth J. Smith, M. Ragni, C. Seaman, 2013, Thrombosis research.

Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients.

J. Fung, V. Scantlebury, R. Shapiro, 2002, Transplantation proceedings.

Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study

D. Perry, L. Valentino, M. Ozelo, 2013 .

Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma.

B. Rabin, J. Lewis, M. Ragni, 1984, The American journal of medicine.

T lymphocyte colony assay in hemophiliacs.

B. Rabin, J. Lewis, M. Ragni, 1984, Blood.

Chest pain, dyspnea, petechiae, and melena in a 58-year-old woman – What is it?

M. Ragni, E. Novelli, R. Mehta, 2013, Platelets.

Liver transplant outcomes in HIV(+) haemophilic men

D. Stablein, P. Stock, M. Ragni, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

R. Hoffmann, C. Leissinger, R. Montgomery, 2013, Blood.

Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies

J. Dumont, D. Quon, J. Staber, 2021, Blood.

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry

P. Marks, A. Angiolillo, L. Valentino, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.

Kenneth J. Smith, D. Bellissimo, E. Kraut, 2023, The Lancet. Haematology.

Survival of human immunodeficiency virus-infected liver transplant recipients.

N. Heaton, S. Belle, P. Stock, 2003, The Journal of infectious diseases.

Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia

J. Li, T. Whiteside, M. Ragni, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C

A. Demetris, J. Fung, M. D. de Vera, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Liver Transplantation in HIV-Seropositive Individuals

N. Heaton, S. Belle, P. Stock, 2006, Annals of Internal Medicine.

Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis

J. Soucie, M. Ragni, B. Wicklund, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: A EHA Consensus Report

P. Noris, A. Tosetto, F. Leebeek, 2019 .

Changing causes of death in Pennsylvania's hemophiliacs 1976 to 1991: impact of liver disease and acquired immunodeficiency syndrome.

S. Shapiro, M. Ragni, S. Cutter, 1992, Blood.

Predictors of Von Willebrand Disease In Children: A Case-Control Study

C. Kempton, P. Kouides, M. Ragni, 2010 .

Rituximab for treatment of inhibitors in haemophilia A

S. Assmann, V. Marder, L. Valentino, 2014, Thrombosis and Haemostasis.

AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations.

J. Levy, J. Lewis, M. Ragni, 1986, Blood.

Factor VIII brand and immunogenicity.

M. Ragni, 2014, Blood.

Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis.

M. Ragni, Craig D. Seaman, 2017, Blood Advances.

Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America

C. Kessler, B. Konkle, C. Manno, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.

J. Gill, G. Castaman, P. Kouides, 2015, Blood.

The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease

M. Ragni, Craig D. Seaman, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults

V. Blanchette, C. Négrier, S. Lethagen, 2023, Research and practice in thrombosis and haemostasis.

A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease

M. Ragni, E. Merricks, R. Jankowitz, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease

R. Watts, E. Kraut, B. Kerlin, 2009, Haemophilia.

Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a

X. Anguela, M. Carr, K. High, 2017 .

Intracellular Co-Localization of Factor VIII and Von Willebrand Factor Is Necessary for In Vivo FVIII Secretion.

M. Ragni, P. Lamont, 2004 .

Pulmonary embolism and spiral computerized tomographic scans

M. Ragni, 2009, Current opinion in pulmonary medicine.

Liver Retransplantation in Patients With HIV‐1 Infection: An International Multicenter Cohort Study

J. Miro, P. Stock, S. Nishida, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.